Paragon 28 Inc.

FNA

Offer Price Offer Size 3-Year Outlook Volatility 1st Day Turnover
$16.00 7,800,000 Positive High 55.72%

Offering Team

Deal Managers

  • Bank of America Merrill Lynch
  • Piper Jaffray

Lawyers

  • Latham & Watkins LLP

Auditors

  • Deloitte & Touche LLP

Pre-IPO Investors

Investors

  • Google Ventures
  • Intel Ventures
  • Patricoff Ventures
  • Kleiner Perkins

Pre-IPO Holdings(%)

  • 30
  • 20
  • 05
  • 18

Deal Highlights

Our mission is to continuously improve the outcomes and experiences of people suffering from foot and ankle conditions. We are a leading medical device company exclusively focused on the foot and ankle orthopedic market and we are dedicated to improving patient lives. Our innovative orthopedic solutions, procedural approaches and instrumentation cover a wide range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive More

Deal Tracker

Investors

Filing

14 Oct, 2021

Offer

15 Oct, 2021

Look Ahead

Lock Up Expiry

15 Apr, 2022

Earning

Nov 1, 2018

IPO Terms

Offer Price $16.00
Offer Size 7M

Market Sentiments

Stock Price